Tag: Matthew Appleton
Firms advise on GSK’s USD2.2bn RAPT buy, accesses China drug
British pharmaceutical giant GSK has entered an agreement to acquire US-based clinical-stage biopharmaceutical company RAPT Therapeutics for around USD2.2 billion
Three firms act on BioNTech’s USD950m China partner buyout
A&O Shearman, Goodwin, and Conyers are advising BioNTech on its $950M buyout of a Chinese cancer drug partner to rival Merck
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
Q&A: INTA’s Walter Chia discusses IP from APAC viewpoint
Walter Chia, the chief representative officer for Asia-Pacific at INTA, elaborates on factors shaping IP across the region
